Bristol Myers Squibb Receives Positive CHMP Opinion for Onureg® as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia in First Remission Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo Plus Yervoy as First-Line Treatment for Unresectable Malignant Pleural Mesothelioma Biotech Investing
AbbVie Receives Health Canada Approval of HUMIRA® for the Treatment of Pediatric Patients with Moderately to Severely Active Ulcerative Colitis Biotech Investing
Ortho Dermatologics Announces Statistically Significant Topline Results From Second Pivotal Phase 3 Clinical Trial Evaluating IDP-126 Gel In Acne Vulgaris Medical Device Investing
BLU NOTICE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against BELLUS Health, Inc.- BLU Biotech Investing
Ortho Dermatologics to Present New Data at the 2021 American Academy of Dermatology Annual Meeting Medical Device Investing
Jamieson Wellness Inc. Announces Date of First Quarter 2021 Financial Results and Conference Call Pharmaceutical Investing
Lobe Sciences Appoints Benjamin Kelmendi, MD from Yale University to Scientific Advisory Board Cannabis Investing News
